Lalpathlab
Live Price
Recent news and updates for LALPATHLAB will appear here soon.
"Caution advised for LALPATHLAB investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
As of the latest market session, Lalpathlab (LALPATHLAB) is trading at ₹1,922.3, representing a move of 1.08% from the previous close.
Lalpathlab is listed and traded under the ticker symbol LALPATHLAB on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Lalpathlab's stock price moved by 1.08%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 35% bullish probability for LALPATHLAB stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Lalpathlab shares reached a high of ₹2,038.6 and hit a low of ₹1,272.6.
LALPATHLAB exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,24,179 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Lalpathlab has a market capitalization of ₹32142.92 Cr, designating its size class inside the Healthcare sector.
Lalpathlab has a current dividend yield of 108.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Lalpathlab's trailing Price-to-Earnings (P/E) ratio is 57.90. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Lalpathlab (LALPATHLAB) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Lalpathlab's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore LALPATHLAB's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for LALPATHLAB are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Lalpathlab operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.